Patents : |  |
| US Patent No. | Title |
| 7427400 | Methods of cancer diagnosis and therapy targeted against a cancer stem line
|
| 7432302 | Composition containing polyamine transport inhibitor and use thereof
|
| 7432304 | Small molecule antagonists of Bcl-2 family proteins
|
| 7432369 | Pyridyl-substituted porphyrin compounds and methods of use thereof
|
| 7435725 | Oral compositions and methods for prevention, reduction and treatment of radiation injury
|
| 7435726 | Compositions and methods for the treatment of cancer
|
| 7435739 | Substituted pyrrolopyrimidines useful in the treatment of cancer
|
| 7435750 | Method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
| 7435755 | CDDO-compounds and combination therapies thereof
|
| 7435808 | Polynucleotides encoding novel adiponectin receptor variant, AdipoR2v2
|
| 7438685 | Apparatus and method for registration, guidance and targeting of external beam radiation therapy
|
| 7432300 | Gossypol co-crystals and the use thereof
|
| 7432285 | Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
|
| 7432064 | Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
|
| 7427616 | Condensed pyridines and pyrimidines with tie2 (TEK) activity
|
| 7427627 | N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds
|
| 7427657 | Aromatic sulfenates for type 1 phototherapy
|
| 7429382 | Antibodies that bind cell-associated CA 125/O772P and methods of use thereof
|
| 7429474 | 2-O sulfatase compositions and methods of analyzing therewith
|
| 7429584 | Furo[2.3-b]pyridine derivatives for the treatment of hyper-proliferative disorders
|
| 7429639 | SSX-2 peptides presented by HLA class II molecules
|
| 7429645 | Humanized anti-lymphotoxin beta receptor antibodies
|
| 7431388 | Chair with a built-in sun-protective device
|
| 7431719 | System for electromagnetic radiation dermatology and head for use therewith
|
| 7438719 | Phototherapy system and device
|
| 7439028 | Methods and compositions to correlate Trichomonas infection with prostate cancer
|
| 7449555 | Antibodies of angiogenesis inhibiting domains CD148
|
| 7452535 | Methods of treatment using CTLA-4 antibodies
|
| 7452537 | P-cadherin antibodies
|
| 7452538 | Death domain containing receptor 4 antibodies and methods
|
| 7454046 | Method and system for analyzing skin conditions using digital images
|
| 7455840 | Compositions and methods to reduce mutagenesis
|
| 7455986 | Heparinase III and methods of specifically cleaving therewith
|
| 7456178 | Compounds, methods and pharmaceutical compositions for inhibiting PARP
|
| 7456256 | BGS 4
|
| 7456289 | Anti-tumor compounds
|
| 7449492 | Therapeutic agents--I
|
| 7449118 | Process for reduction of inorganic contaminants from waste streams
|
| 7446230 | Dibenzoylmethane-based compounds, use as photoactivatable sunscreens and cosmetic compositions containing them
|
| 7442512 | Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
| 7442697 | 4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity
|
| 7442778 | Modified Fc molecules
|
| 7442802 | Cyclooxygenase-2 selective inhibitors, compositions and methods of use
|
| 7445718 | Removal of arsenic from drinking and process water
|
| 7445794 | Methods for treating human proliferative diseases, with a combination of fatty acid metabolism inhibitors and glycolytic inhibitors
|
| 7445906 | Method of detecting cancer using delta-catenin
|
| 7446105 | Pyrimidine compounds
|
| 7446122 | Substituted indole derivatives
|
| 7446176 | 12 human secreted proteins
|
| 7457659 | Method and device for examining the skin
|
